Long COVID: pilot trial of online meditation suggests relief from some symptoms

An online breathing and meditation program could ease some long COVID symptoms. In a randomized pilot trial, participants offered the program reported better outcomes on several measures of fatigue, mood and breathlessness than those placed on a waiting list. But incomplete data and the short follow-up prevent conclusions about lasting effectiveness.

Illustration of a remotely guided breathing and meditation session.
MindsetEditorial illustration, not study data.

A three-week program compared with a waiting list

The study involved adults aged 18 to 70 with physician-confirmed long COVID, recruited in the United States. Of 189 people randomized, 188 started the study after one exclusion for a protocol deviation.

Participants were assigned to either immediate access to the program or a waiting list. The program combined three yogic breathing and meditation practices, delivered through live webinars and videos for independent daily practice. The waiting-list group received access after three weeks. The study lasted six weeks in total.

The primary outcome was not symptom improvement, but adherence to the program. Symptoms, stress and quality of life were secondary outcomes.

Encouraging signals, without demonstrated improvement across all outcomes

Compared with the waiting-list group, the group given immediate access to the program showed greater reductions in overall mood disturbance, fatigue, certain dimensions of perceived breathlessness and somatic symptom burden. Positive mood and vigor also improved more.

However, between-group differences in stress and quality of life were not statistically significant. The results therefore do not support claims of an overall improvement in long COVID.

The abstract reports differences on symptom scales but does not provide the thresholds needed to determine whether these differences represent clinically meaningful improvement. A statistical difference alone is not enough to establish a noticeable benefit in daily life.

Adherence remains difficult to assess

Of the 188 participants who started the study, 124 reached the active intervention period. Complete adherence data were available for only 58 people. Among them, 55% had practiced at least one technique four days a week or more during the three weeks.

This percentage therefore does not describe all participants. Missing data limit the assessment of feasibility, even though the remote format may help address some barriers to accessing care.

No adverse events were reported. This does not demonstrate an absence of risk, particularly beyond the short period studied.

Potential support, not proof of lasting recovery

The waiting-list comparison does not isolate the specific effect of the techniques from that of support or participants’ expectations. The abstract also reports several secondary analyses without specifying how multiple comparisons were accounted for.

Above all, the result warrants further evaluation. It demonstrates neither lasting recovery, nor a change in the mechanisms of long COVID, nor the possibility of replacing existing care.

Limitations to keep in mind

Analysis based solely on the supplied PubMed abstract, without consulting the full text. Short pilot trial, waiting-list comparator, largely incomplete adherence data and several secondary outcomes. Funding and conflicts of interest were not verified in the dossier.

What we can take away

This online program provides a preliminary signal for some self-reported long COVID symptoms. Its clinical benefit, feasibility and lasting effects still need to be confirmed.

Sources and provenance

Partager cet article

X f in

An error or a source to report? Contact the editorial team.